Skip to content

Addiction: all studies

Page 489 of 860: studies 4,881 to 4,890 of 8,594, newest first. Back to the addiction overview

Research

Navigating through the ebbs and flows of language.

Current Opinion in Neurobiology October 2021 Aline Viol, Alessandro Treves, Elisa Ciaramelli

Is progress in understanding the neural basis for spatial navigation relevant to the human language faculty? Not so much at the shortest scale, where movement is continuous, a recent study in the space of vowels suggests. At a much larger scale, however, that of the verbalization of run-away thoughts, a rich phenomenology appears to involve critical contributions by some of the brain structures...

Evaluation of Cognitive Behavioral Therapy vs Mindfulness Meditation in Brain Changes During Reappraisal and Acceptance Among Patients With Social Anxiety Disorder: A Randomized Clinical Trial.

JAMA Psychiatry October 1, 2021 Philippe R. Goldin, Matthew D Thurston, Santiago Allende et al.

Cognitive behavioral group therapy (CBGT) and mindfulness-based stress reduction (MBSR) are thought to help patients with social anxiety disorder (SAD) via distinct emotion-regulation mechanisms. However, no study has compared the effects of CBGT and MBSR on brain and negative emotion indicators of cognitive reappraisal and acceptance in patients with SAD. To investigate the effects of CBGT and...

A systematic review of the effects of cannabis on cognition in people with multiple sclerosis.

Multiple sclerosis and related disorders October 1, 2021 Jeffrey Landrigan, Kitti Bessenyei, Damian Leitner et al.

BACKGROUND Multiple sclerosis (MS) is a chronic demyelinating disease which leads to sensory, motor, autonomic, and cognitive symptoms. Cannabis is a common way for persons with MS (pwMS) to seek symptomatic therapy. Given the capacity for both cannabis and MS to cause cognitive impairment, it is important to determine whether there is any negative impact when the two co-occur. The objective of...

Cannabis-induced psychosis masquerading schizophrenia or vice-versa? A diagnostic dilemma

Industrial Psychiatry Journal October 1, 2021 Rachit Sharma, Ayushma Shah

Clinical features of schizophrenia and cannabis-induced psychosis (CIP) share many overlapping characteristics. We present a case of Cannabis Dependence Syndrome, whose first presentation was with first-rank symptoms of schizophrenia in the form of thought insertion, withdrawal and delusion of control.

Refuting the unfolding-argument on the irrelevance of causal structure to consciousness.

Consciousness and Cognition October 1, 2021 M. Usher

The unfolding argument (UA) was advanced as a refutation of prominent theories, which posit that phenomenal experience is determined by patterns of neural activation in a recurrent (neural) network (RN) structure. The argument is based on the statement that any input-output function of an RN can be approximated by an "equivalent" feedforward-network (FFN). According to UA, if consciousness...

Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study.

Drug and Alcohol Dependence October 1, 2021 Valerio Ricci, Franca Ceci, Francesco di Carlo et al.

BACKGROUND Cannabis is the most used recreational drug worldwide. Its use can increase the risk of developing psychotic disorders and exacerbate their course. However, the relationship between cannabis use and dissociative symptoms has been scarcely investigated. AIMS To examine differences in psychotic and dissociative symptoms, and in functioning in first-episode psychotic patients (FEPp)...

How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter.

Biochemical Pharmacology October 1, 2021 Alexandra Sachkova, David Alexander Doetsch, Ole Jensen et al. 11 citations

Although psychostimulants apparently do cross the BBB, it is poorly understood how these hydrophilic and positively charged molecules can pass the blood-brain barrier (BBB). That may be mediated by a genetically still uncharacterized H+/OC antiporter with high activity at the BBB. We studied the uptake of 16 psychostimulants and hallucinogens with hCMEC/D3 cells using the prototypic inhibitor...

DOI: 10.1016/j.bcp.2021.114751 (opens in new tab) Full text (opens in new tab) Hallucinogen Organic cation transporter Proton-organic cation antiporter Psychostimulant +2

The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL/6J mice.

Behavioural Brain Research October 1, 2021 Anna Rafało-Ulińska, Agnieszka Pałucha-Poniewiera 46 citations

(S)-ketamine has been approved as a rapid-acting antidepressant drug (RAAD). Although ketamine has an advantage over classic antidepressants (ADs) due to its rapid action, it remains a controversial drug due to its undesirable effects. Behavioral studies indicate that another enantiomer of ketamine, namely, (R)-ketamine, has been proposed as a safer but still effective RAAD. However, these...

The dynamic framework of mind wandering revisited: How mindful meta-awareness affects mental states' constraints.

Consciousness and Cognition October 1, 2021 Shaghayegh Konjedi, Reza Maleeh 8 citations

The dynamic framework of mind wandering (Christoff, Irving, Fox, Spreng, & Andrews-Hanna, 2016) is reviewed and modified through integrating the construct of mindful meta-awareness. The dynamic framework maintains that mind wandering belongs to a family of spontaneous thought phenomena. The key defining feature of mind wandering is 'spontaneity' which characterizes the dynamic nature of...

DOI: 10.1016/j.concog.2021.103194 (opens in new tab) Full text (opens in new tab) Cognitive control Dynamic framework Mental flexibility Mindful meta-awareness +1

Opioids cause dissociated states of consciousness in C57BL/6J mice.

Journal of Neurophysiology October 1, 2021 Christopher B O'Brien, Clarence E Locklear, Zachary T Glovak et al. 18 citations

The electroencephalogram (EEG) provides an objective, neural correlate of consciousness. Opioid receptors modulate mammalian neuronal excitability, and this fact was used to characterize how opioids administered to mice alter EEG power and states of consciousness. The present study tested the hypothesis that antinociceptive doses of fentanyl, morphine, or buprenorphine differentially alter the...

DOI: 10.1152/jn.00266.2021 (opens in new tab) Full text (opens in new tab) Buprenorphine Correlates of consciousness Fentanyl Morphine +1